![](/img/cover-not-exists.png)
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML
Schütz, C, Inselmann, S, Sausslele, S, Dietz, C T, Müller, M C, Eigendorff, E, Brendel, C A, Metzelder, S K, Brümmendorf, T H, Waller, C, Dengler, J, Goebeler, M E, Herbst, R, Freunek, G, Hanzel, S,Volume:
31
Language:
english
Journal:
Leukemia
DOI:
10.1038/leu.2017.9
Date:
April, 2017
File:
PDF, 1.79 MB
english, 2017